for Journals by Title or ISSN
for Articles by Keywords
Followed Journals
Journal you Follow: 0
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover The Rose Sheet
  [1 followers]  Follow
   Full-text available via subscription Subscription journal  (Not entitled to full-text)
   ISSN (Print) 1530-1222
   Published by Informa plc Homepage  [16 journals]
  • New Products In Brief: L’Oreal’s Emoji Keyboard; Latest Elos Device;
    • Abstract: L’Oreal USA advances the firm’s digital innovation strategy with the launch of Beaumoji, a freely downloadable keyboard that gives beauty lovers 130 new emojis to enhance their social messaging. More new products in brief.
      PubDate: Thu, 07 Jul 2016 18:00:02 -040
  • DERMAFLASH Dual-Benefit Device Maker Targets $10M In
           First-Year Sales
    • Abstract: Designed both for facial exfoliation and “peach fuzz” removal, DD Karma’s $189 DERMAFLASH system provides a smooth canvas that facilitates skin-care and makeup application. The company is focused on educating sales personnel and teaming with traditional beauty brands while continuing to roll out to luxury and specialty retailers around the US.
      PubDate: Thu, 07 Jul 2016 17:55:00 -040
  • WEN Class Action Headed For Potential $26M Settlement
           In California
    • Abstract: Individuals with documented hair loss or other injuries attributed to use of WEN Cleansing Conditioners could be compensated with payments up to $20,000 apiece under a proposed settlement expected to be entered in California’s Central District at the start of August.
      PubDate: Wed, 06 Jul 2016 15:20:05 -040
  • FDA Tests WEN Conditioner’s MI/MCI Content In Pursuit Of Hair-Loss
    • Abstract: The MI/MCI preservative combination is a suspect being explored by FDA as part of its investigation into reports of hair loss and other adverse effects linked to WEN Cleansing Conditioners. The agency discusses testing it undertook to quantitate the WEN products’ MI/MCI content in a response to concerns raised by Democratic Congressman Frank Pallone of New Jersey.
      PubDate: Wed, 06 Jul 2016 15:20:03 -040
  • FDA To Congressman Pallone: Probe Into WEN
           Conditioner AEs Continues
    • Abstract: FDA’s investigation is “active and ongoing” into AE reports linking WEN Cleansing Conditioners to hair loss, irritation and rashes. In a letter obtained by the Rose Sheet through a Freedom of Information Act request, the agency addresses questions posed by Democratic Congressman Frank Pallone regarding its regulatory response to date and related exchanges with manufacturer Guthy-Renker and creator Chaz Dean.
      PubDate: Wed, 06 Jul 2016 15:20:01 -040
  • Truth Decay' ASA Examines Brush Maker’s Dentist-Recommended
    • Abstract: A preference poll of 46 dentists – used to support Wisdom Toothbrushes’ claim “Recommended by 100% of dental professionals” – was central to a dispute between oral-care rivals adjudicated by the UK’s Advertising Standards Authority, which published its decision in the matter June 29.
      PubDate: Thu, 30 Jun 2016 16:35:01 -040
  • Post-Brexit, EU Cosmetics Regulation Will Remain ‘Passport For
    • Abstract: The future of cosmetics regulation in the UK may be among the least of uncertainties in the aftermath of Brexit.
      PubDate: Thu, 30 Jun 2016 12:20:00 -040
  • FDA Among Regulatory Authorities Reeling From Brexit Bombshell
    • Abstract: Commissioner Robert Califf says FDA has no firm plan but will “react to whatever happens” following the UK’s momentous decision to leave the EU. The European Medicines Agency also is taking a wait-and-see approach, while regulated industries brace for potential compliance, R&D and IP challenges in Brexit’s aftermath.
      PubDate: Wed, 29 Jun 2016 19:45:01 -040
  • EU Industry Guidance Supports Essential Oil Eco-Assessment
    • Abstract: While no “definitive methodology” for assessing environmental risks associated with essential oils and other natural complex substances, the new guidance should help steer producers and cosmetic manufacturers in their efforts to compile and assess data for compliance with the EU’s REACH and CLP regs.
      PubDate: Wed, 29 Jun 2016 11:50:01 -040
  • NAD Continues To Wear Consumer’s Shoes When Assessing
           ‘Natural’ Claims
    • Abstract: Much has changed since the National Advertising Division reviewed Tom’s Of Maine’s Natural Mouthwash claims in 1998, referring at the time to the “small segment of consumers that have heightened concerns and expectations” regarding natural products. Despite the market’s explosion, “natural” remains undefined by regulators, and NAD continues to assess the truthfulness of claims on a case-by-case basis.
      PubDate: Tue, 28 Jun 2016 15:55:00 -040
  • NAD: Anti-Aging Claims ‘Muted A Bit,’ But Vigilance Remains
    • Abstract: Anti-aging claims in the cosmetics sector show improved compliance with advertising standards overall, but the National Advertising Division remains on the lookout for potential overstatements, particularly as personal-care companies are less inclined to challenge each other than players in other industries.
      PubDate: Tue, 28 Jun 2016 15:45:02 -040
  • Weekly Trademark Review June 21, 2016
    • Abstract: Trademark filings compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
      PubDate: Mon, 27 Jun 2016 11:30:02 -040
  • Weekly Trademark Review June 14, 2016
    • Abstract: Personal care product and cosmetic trademark filings compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
      PubDate: Mon, 27 Jun 2016 11:10:01 -040
  • Editor's Note: Dietary Supplement Coverage Coming Soon On New Rose Sheet
           Web Platform
    • Abstract: The Rose Sheet’s cosmetics industry coverage and analysis will continue uninterrupted come mid-July, but readers will gain access to high-level insight into dietary supplement sector developments from the expert editorial staff of our previously affiliated publication, the Tan Sheet. All will be delivered through an updated web platform at the same URL, with no change to your current subscription or login credentials.
      PubDate: Mon, 27 Jun 2016 00:01:50 -040
  • FDA May Well Need OTC Drug Funding, But Stakeholders Want Program
    • Abstract: The monograph program was "instituted, really, many, many decades ago. We've been trying to implement it since," said CDER Director Janet Woodcock at a recent FDA hearing.
      PubDate: Fri, 24 Jun 2016 15:30:01 -040
  • EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO
    • Abstract: The European Commission’s newly released criteria for identifying endocrine disruptors in the plant-protection and biocidal product sectors have no direct regulatory impact on cosmetics, but could signal the approach the EC will take in other areas as it works to manage endocrine-disruptor risks. A review of the Cosmetics Regulation’s applicability to endocrine disruptors is nearing completion, the EC says.
      PubDate: Fri, 24 Jun 2016 13:10:02 -040
  • Revlon Targets Prestige Channel, Fragrance Growth With Elizabeth Arden Buy
    • Abstract: Firm’s $870m acquisition of Elizabeth Arden is seen as “highly complementary,” bringing prestige skin care and scalable fragrance licenses to its existing business focused on mass and salon beauty and hair care. The deal also offers synergies and cost-reduction opportunities for both companies, which have struggled in recent years to rejuvenate their businesses.
      PubDate: Thu, 23 Jun 2016 16:35:00 -040
  • Colgate Max White 'Instant' Benefit Claims Not
           Exaggerated Overall – ASA
    • Abstract: A Colgate-Palmolive clinical study for Max White One Optic toothpaste adequately supports its "instantly whiter" advertising in the UK, but results were not so pronounced as to justify a "much whiter" claim, according to the Advertising Standards Authority. Procter & Gamble UK was the challenger in the case.
      PubDate: Wed, 22 Jun 2016 09:45:02 -040
  • Cosmetics Europe Looks To "Future-Proof" Industry Amid Global Changes
    • Abstract: In a report released during its Cosmetics Europe Week, the European trade association highlights the personal-care industry's socio-economic contributions and emerging challenges it must face in a global marketplace marked by growing interconnectivity, digitalization and social/environmental consciousness.
      PubDate: Wed, 22 Jun 2016 09:35:02 -040
  • Cosmetic Ingredient Review Report Status
    • Abstract: Chart: Data compiled by "The Rose Sheet" from information in CIR reports.
      PubDate: Mon, 20 Jun 2016 15:00:27 -040
  • CIR Panel Emphasizes GMPs In Final 'Safe As Used' Ingredient Reports
    • Abstract: Hexamethylene diisocyanate polymers and keratin/keratin-derived ingredients are safe as currently used in the cosmetics sector, provided that good manufacturing practices are being employed, the Cosmetic Ingredient Review Expert Panel suggests. The group issued four final assessments, advanced a slew of tentative reports and finalized its 2017 review priorities at its June 6-7 meeting in Washington.
      PubDate: Mon, 20 Jun 2016 15:00:20 -040
  • In Brief: Australian Cosmetic Animal-Test Ban; Revlon Buys Cutex
           International; More
    • Abstract: Australia's cosmetic market will be cruelty-free beginning in July 2017, according to a June 3 announcement. More news in brief.
      PubDate: Sun, 19 Jun 2016 19:15:01 -040
  • PCPC: 'Double Fees' For Cosmetic-Drug Products Are Regulatory Reform
    • Abstract: Cosmetic products containing OTC drug ingredients – such as acne-fighting agents and UV filters in skin-care and makeup items, fluoride in toothpaste and dandruff medication in shampoo – could be subject to multiple fees if FDA's concept for generating OTC monograph program funding were to become a reality along with the Personal Care Products Safety Act.
      PubDate: Fri, 17 Jun 2016 16:00:01 -040
  • Industry Wary Of OTC Monograph User-Fees Concept
    • Abstract: Executives from OTC drug manufacturers expressed doubts at a June 10 public meeting about the equity and utility of a program FDA is considering that would impose user fees on firms that make or market monograph drugs, the vast majority of nonprescription pharmaceutical products.
      PubDate: Thu, 16 Jun 2016 17:40:01 -040
  • 'Real Challenge' To Improve OTC Monograph Program Without User Fees
           – FDA
    • Abstract: FDA is weighing the potential benefits of, and drawbacks to, establishing user fees to support its OTC drug monograph program, opening a docket for comments and conducting a June 10 public meeting on the subject. Industry seems far from on board at present, and FDA also acknowledges that there could be downsides to a user fee program in addition to potential benefits for companies and consumers.
      PubDate: Thu, 16 Jun 2016 17:35:03 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
Home (Search)
Subjects A-Z
Publishers A-Z
Your IP address:
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2016